Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Select Drug Profiles
Hidden Cost of Treatment: Side Effects
C. Daniel Mullins, PhD
Read More
Finding Value in Healthcare
C. Daniel Mullins, PhD
Read More
Benefits of the Single Payer Perspective
Andrew Stainthorpe, PhD
Read More
Oncology Pharmacist's Role in Cancer Care
Gary M. Owens, MD
Read More
Bringing the Patient into the Conversation
Andrew Stainthorpe, PhD
Read More
Using Research to Guide Quality and Quantity of Care
Andrew Stainthorpe, PhD
Read More
AMCP Weighs in on Cost-Effectiveness
C. Daniel Mullins, PhD
Read More
Quality versus Cost
C. Daniel Mullins, PhD
Read More
Cost of Cancer Care and Complexities of Cost-Sharing
Gary M. Owens, MD
Read More
Keeping Cost Out of the Drug Approval Debate
Andrew Stainthorpe, PhD
Read More
136
137
138
139
140
141
142
Page 139 of 244
Results 1381 - 1390 of 2434